Cite

HARVARD Citation

    Ma, M. et al. (2016). Xc− inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism. Cancer letters. 368 (1), pp. 88-96. [Online]. 
  
Back to record